Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): Primary analysis of a prospective, multicenter, response-adapted study.

View Full Paper
Ask AI
Bookmark
Share

Authors

FWFei WangYWYongjiu WangBXBin Xiong

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e674d2b6db6435875fecechttps://doi.org/10.1200/jco.2024.42.16_suppl.603
View Full Paper
Ask AI
Bookmark
Share